Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Sensitive method for endotoxin determination in nanomedicinal product samples.

Giannakou C, Aimonen K, Bloois LV, Catalán J, Geertsma RE, Gremmer ER, de Jong WH, Keizers PH, Schwillens PL, Vandebriel RJ, Park MV.

Nanomedicine (Lond). 2019 May;14(10):1231-1246. doi: 10.2217/nnm-2018-0339.

PMID:
31124759
2.

Head skeleton malformations in zebrafish (Danio rerio) to assess adverse effects of mixtures of compounds.

Staal YCM, Meijer J, van der Kris RJC, de Bruijn AC, Boersma AY, Gremmer ER, Zwart EP, Beekhof PK, Slob W, van der Ven LTM.

Arch Toxicol. 2018 Dec;92(12):3549-3564. doi: 10.1007/s00204-018-2320-y. Epub 2018 Oct 4.

3.

Is current risk assessment of non-genotoxic carcinogens protective?

Braakhuis HM, Slob W, Olthof ED, Wolterink G, Zwart EP, Gremmer ER, Rorije E, van Benthem J, Woutersen R, van der Laan JW, Luijten M.

Crit Rev Toxicol. 2018 Jul;48(6):500-511. doi: 10.1080/10408444.2018.1458818. Epub 2018 May 10.

PMID:
29745287
4.

Compound- and sex-specific effects on programming of energy and immune homeostasis in adult C57BL/6JxFVB mice after perinatal TCDD and PCB 153.

van Esterik JC, Verharen HW, Hodemaekers HM, Gremmer ER, Nagarajah B, Kamstra JH, Dollé ME, Legler J, van der Ven LT.

Toxicol Appl Pharmacol. 2015 Dec 1;289(2):262-75. doi: 10.1016/j.taap.2015.09.017. Epub 2015 Sep 28.

PMID:
26415833
5.

A Dose-Response Modeling Approach Shows That Effects From Mixture Exposure to the Skin Sensitizers Isoeugenol and Cinnamal Are in Line With Dose Addition and Not With Synergism.

Kienhuis AS, Slob W, Gremmer ER, Vermeulen JP, Ezendam J.

Toxicol Sci. 2015 Sep;147(1):68-74. doi: 10.1093/toxsci/kfv109. Epub 2015 Jun 4.

PMID:
26048650
6.

Developmental immunotoxicity testing of 4-methyl anisole.

Tonk EC, Verhoef A, Gremmer ER, van Loveren H, Piersma AH.

Regul Toxicol Pharmacol. 2015 Jul;72(2):379-85. doi: 10.1016/j.yrtph.2015.04.003. Epub 2015 Apr 14.

PMID:
25882306
7.

Immunotoxicity of silver nanoparticles in an intravenous 28-day repeated-dose toxicity study in rats.

Vandebriel RJ, Tonk EC, de la Fonteyne-Blankestijn LJ, Gremmer ER, Verharen HW, van der Ven LT, van Loveren H, de Jong WH.

Part Fibre Toxicol. 2014 May 7;11:21. doi: 10.1186/1743-8977-11-21.

8.

Sub-chronic toxicity study in rats orally exposed to nanostructured silica.

van der Zande M, Vandebriel RJ, Groot MJ, Kramer E, Herrera Rivera ZE, Rasmussen K, Ossenkoppele JS, Tromp P, Gremmer ER, Peters RJ, Hendriksen PJ, Marvin HJ, Hoogenboom RL, Peijnenburg AA, Bouwmeester H.

Part Fibre Toxicol. 2014 Feb 7;11:8. doi: 10.1186/1743-8977-11-8.

9.

Statin use and markers of immunity in the Doetinchem cohort study.

De Jong HJ, Damoiseaux JG, Vandebriel RJ, Souverein PC, Gremmer ER, Wolfs M, Klungel OH, Van Loveren H, Cohen Tervaert JW, Verschuren WM.

PLoS One. 2013 Oct 16;8(10):e77587. doi: 10.1371/journal.pone.0077587. eCollection 2013.

10.

Developmental immunotoxicity in male rats after juvenile exposure to ethanol.

Tonk EC, Verhoef A, Gremmer ER, van Loveren H, Piersma AH.

Toxicology. 2013 Jul 5;309:91-9. doi: 10.1016/j.tox.2013.04.003. Epub 2013 Apr 25.

PMID:
23623904
11.

Response to 'Statins accelerate the onset of collagen type II-induced arthritis in mice'-authors' reply.

Vandebriel RJ, De Jong HJ, Gremmer ER, Klungel OH, Tervaert JW, Slob W, Van Der Laan JW, Van Loveren H.

Arthritis Res Ther. 2013 Mar 8;15(2):403. doi: 10.1186/ar4170. No abstract available.

12.

Induction of skin sensitization is augmented in Nrf2-deficient mice.

van der Veen JW, Gremmer ER, Vermeulen JP, van Loveren H, Ezendam J.

Arch Toxicol. 2013 Apr;87(4):763-6. doi: 10.1007/s00204-012-0976-2. Epub 2012 Nov 11.

PMID:
23143620
13.

Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure.

van der Zande M, Vandebriel RJ, Van Doren E, Kramer E, Herrera Rivera Z, Serrano-Rojero CS, Gremmer ER, Mast J, Peters RJ, Hollman PC, Hendriksen PJ, Marvin HJ, Peijnenburg AA, Bouwmeester H.

ACS Nano. 2012 Aug 28;6(8):7427-42. doi: 10.1021/nn302649p. Epub 2012 Aug 9.

PMID:
22857815
14.

Statins accelerate the onset of collagen type II-induced arthritis in mice.

Vandebriel RJ, De Jong HJ, Gremmer ER, Klungel OH, Tervaert JW, Slob W, Van Der Laan JW, Van Loveren H.

Arthritis Res Ther. 2012 Apr 26;14(2):R90. doi: 10.1186/ar3814.

15.

Relative sensitivity of developmental and immune parameters in juvenile versus adult male rats after exposure to di(2-ethylhexyl) phthalate.

Tonk EC, Verhoef A, Gremmer ER, van Loveren H, Piersma AH.

Toxicol Appl Pharmacol. 2012 Apr 1;260(1):48-57. doi: 10.1016/j.taap.2012.01.018. Epub 2012 Jan 31.

PMID:
22310177
16.

Effects of Bifidobacterium animalis administered during lactation on allergic and autoimmune responses in rodents.

Ezendam J, de Klerk A, Gremmer ER, van Loveren H.

Clin Exp Immunol. 2008 Dec;154(3):424-31. doi: 10.1111/j.1365-2249.2008.03788.x.

17.

The role of Toll-like receptor-4 in pertussis vaccine-induced immunity.

Banus S, Stenger RM, Gremmer ER, Dormans JA, Mooi FR, Kimman TG, Vandebriel RJ.

BMC Immunol. 2008 May 22;9:21. doi: 10.1186/1471-2172-9-21.

18.

Supplementation of whole-cell pertussis vaccines with lipopolysaccharide analogs: modification of vaccine-induced immune responses.

Geurtsen J, Fransen F, Vandebriel RJ, Gremmer ER, de la Fonteyne-Blankestijn LJ, Kuipers B, Tommassen J, van der Ley P.

Vaccine. 2008 Feb 13;26(7):899-906. doi: 10.1016/j.vaccine.2007.12.012. Epub 2007 Dec 31.

PMID:
18207288
19.

Comparative gene expression profiling in two congenic mouse strains following Bordetella pertussis infection.

Banus S, Vandebriel RJ, Pennings JL, Gremmer ER, Wester PW, van Kranen HJ, Breit TM, Demant P, Mooi FR, Hoebee B, Kimman TG.

BMC Microbiol. 2007 Oct 12;7:88.

20.

Consequences of the expression of lipopolysaccharide-modifying enzymes for the efficacy and reactogenicity of whole-cell pertussis vaccines.

Geurtsen J, Vandebriel RJ, Gremmer ER, Kuipers B, Tommassen J, van der Ley P.

Microbes Infect. 2007 Jul;9(9):1096-103. Epub 2007 May 17.

PMID:
17644385
21.

Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.

Geurtsen J, Banus HA, Gremmer ER, Ferguson H, de la Fonteyne-Blankestijn LJ, Vermeulen JP, Dormans JA, Tommassen J, van der Ley P, Mooi FR, Vandebriel RJ.

Clin Vaccine Immunol. 2007 Jul;14(7):821-9. Epub 2007 May 9.

22.

Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.

Vandebriel RJ, Gremmer ER, Vermeulen JP, Hellwig SM, Dormans JA, Roholl PJ, Mooi FR.

Vaccine. 2007 Mar 8;25(12):2346-60. Epub 2006 Dec 12.

PMID:
17224216
23.

Effects of a diphtheria-tetanus-acellular pertussis vaccine on immune responses in murine local lymph node and lung allergy models.

Vandebriel RJ, Gremmer ER, van Hartskamp M, Dormans JA, Mooi FR.

Clin Vaccine Immunol. 2007 Mar;14(3):211-9. Epub 2007 Jan 3.

24.

Evaluation of immunomodulation by Lactobacillus casei Shirota: immune function, autoimmunity and gene expression.

Baken KA, Ezendam J, Gremmer ER, de Klerk A, Pennings JL, Matthee B, Peijnenburg AA, van Loveren H.

Int J Food Microbiol. 2006 Oct 15;112(1):8-18. Epub 2006 Jul 26.

PMID:
16875751
25.

Use of the local lymph node assay in assessment of immune function.

van den Berg FA, Baken KA, Vermeulen JP, Gremmer ER, van Steeg H, van Loveren H.

Toxicology. 2005 Jul 1;211(1-2):107-14. Epub 2005 Apr 7.

PMID:
15863253

Supplemental Content

Loading ...
Support Center